Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R F Ambinder

Showing results (11-20 of 105) with videos related to

Pageof 11
Sort By:
Human Pathology|June 1, 1994
Epstein-Barr-encoded RNA in situ hybridization: diagnostic applicationsR F Ambinder, R B Mann
Current Opinion in Oncology|September 1, 1996
AIDS primary central nervous system lymphomaI W Flinn, R F Ambinder
Journal of Virology|September 1, 1997
Mapping promoter regions that are hypersensitive to methylation-mediated inhibition of transcription: application of the methylation cassette assay to the Epstein-Barr virus major latency promoterK D Robertson, R F Ambinder
Current Opinion in Oncology|November 5, 1997
Human herpesvirus-8M L Gillison, R F Ambinder
Current Opinion in Infectious Diseases|October 13, 2006
AIDS oncologyI W Flinn, R F Ambinder
Blood|December 31, 1997
Methylation of the Epstein-Barr virus genome in normal lymphocytesK D Robertson, R F Ambinder
Current Opinion in Oncology|October 1, 1991
Biology of the lymphomas: cytogenetics, molecular biology, and virologyR F Ambinder, C A Griffin
The American Journal of Pathology|August 1, 1994
Detection and characterization of Epstein-Barr virus in clinical specimensR F Ambinder, R B Mann
Seminars in Cancer Biology|November 5, 1999
DNA methylation and the Epstein-Barr virusR F Ambinder, K D Robertson, Q Tao
The American Journal of Pathology|May 20, 1998
Epstein-Barr virus (EBV) variant with a 30-bp deletion at the carboxyl terminus (amino acids 346-355) of latent membrane protein-1 (LMP1) gene is able to transform cells and evade immune surveillanceQ Tao, R F Ambinder, L J Swinnen
Pageof 11

Showing results (11-20 of 105) with videos related to

Sort By:
Pageof 11
Human Pathology|June 1, 1994
Epstein-Barr-encoded RNA in situ hybridization: diagnostic applicationsR F Ambinder, R B Mann
Current Opinion in Oncology|September 1, 1996
AIDS primary central nervous system lymphomaI W Flinn, R F Ambinder
Journal of Virology|September 1, 1997
Mapping promoter regions that are hypersensitive to methylation-mediated inhibition of transcription: application of the methylation cassette assay to the Epstein-Barr virus major latency promoterK D Robertson, R F Ambinder
Current Opinion in Oncology|November 5, 1997
Human herpesvirus-8M L Gillison, R F Ambinder
Current Opinion in Infectious Diseases|October 13, 2006
AIDS oncologyI W Flinn, R F Ambinder
Blood|December 31, 1997
Methylation of the Epstein-Barr virus genome in normal lymphocytesK D Robertson, R F Ambinder
Current Opinion in Oncology|October 1, 1991
Biology of the lymphomas: cytogenetics, molecular biology, and virologyR F Ambinder, C A Griffin
The American Journal of Pathology|August 1, 1994
Detection and characterization of Epstein-Barr virus in clinical specimensR F Ambinder, R B Mann
Seminars in Cancer Biology|November 5, 1999
DNA methylation and the Epstein-Barr virusR F Ambinder, K D Robertson, Q Tao
The American Journal of Pathology|May 20, 1998
Epstein-Barr virus (EBV) variant with a 30-bp deletion at the carboxyl terminus (amino acids 346-355) of latent membrane protein-1 (LMP1) gene is able to transform cells and evade immune surveillanceQ Tao, R F Ambinder, L J Swinnen
Pageof 11